Labeltemplate: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
: <BIG><BIG>'''[[Labeltemplate adverse reactions#Clinical Trials Experience|Clinical Trials Experience]]'''</BIG></BIG> | : <BIG><BIG>'''[[Labeltemplate adverse reactions#Clinical Trials Experience|Clinical Trials Experience]]'''</BIG></BIG> | ||
: <BIG><BIG>'''[[Labeltemplate adverse reactions#Postmarketing Experience|Postmarketing Experience]]'''</BIG></BIG> | : <BIG><BIG>'''[[Labeltemplate adverse reactions#Postmarketing Experience|Postmarketing Experience]]'''</BIG></BIG> | ||
Revision as of 20:51, 17 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For information about (Drug), click here.